Home
About
Overview
Management Team
Board of Directors
Scientific Advisors
Science
Overview
Platform Technology
Pipeline
News & Media
Press Releases
Publications
Events
Media
Investors
Overview
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
Contact
Careers
Search
Submit
Presentations
Investors
Investors
Overview
News / Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Presentations
Management Team
Contacts
FAQ
Financial Info
Overview
Balance Sheet
Income Statement
Cash Flow
Financial Results
Stock Data
Overview
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
Company Information
Overview
Presentations
Management Team
Contacts
FAQ
Q3 2020 Shareholder Presentation
Nov 16, 2020
Investor Presentation
Oct 20, 2020
Q2 2020 Shareholder Presentation
Aug 13, 2020
Q1 2020 Shareholder Presentation
May 14, 2020
CXCR4 Inhibitor Program Presentation
Jan 8, 2020
Anti-Fibrotic Program Presentation
Dec 16, 2019
Key Opinion Leader Call on Mitochondria – A Source for Novel Therapeutics – Presentation
May 2, 2019
Key Opinion Leader Call on Mitochondria – A Source for Novel Therapeutics – Audio Replay
May 2, 2019
